---
authors:
- Slawson, David C
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36689984/
file_path: 2023/01/pharmacogenomic-testing-for-selection-of-antidepressant-prov.md
issue: '1'
keywords:
- Pharmacogenomic Testing
- Humans
- Antidepressive Agents
- Pharmacogenetics
- Genetic Testing
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Pharmacogenomic Testing
- Antidepressive Agents
- Genetic Testing
- Pharmacogenetics
original_format: PubMed
pages: 97-98
patient_population: Adults
peer_reviewed: true
pmid: '36689984'
processed_date: '2025-07-30'
publication_date: '2023-01-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-07-30'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal, If Any, Benefit.
topics:
- Family Medicine
volume: '107'
---

# Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal, If Any, Benefit.

**Authors:** Slawson, David C

**Published in:** American family physician | Vol. 107, No. 1 | 2023-01-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36689984/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Pharmacogenomic Testing, Antidepressive Agents, Genetic Testing, Pharmacogenetics

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36689984/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
